vs
BillionToOne, Inc.（BLLN）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是BillionToOne, Inc.的1.1倍（$94.3M vs $83.5M），REPUBLIC BANCORP INC净利率更高（24.2% vs 6.8%，领先17.4%），BillionToOne, Inc.同比增速更快（117.4% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $6.5M）
BillionToOne, Inc.是一家生命科学与分子诊断企业，专注研发高精度基因检测解决方案，核心产品包括无创产前检测、肿瘤诊断试剂及罕见病筛查服务，服务全球多地的医疗机构、患者及科研合作方。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
BLLN vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.1倍
$83.5M
营收增速更快
BLLN
高出112.1%
5.3%
净利率更高
RBCAA
高出17.4%
6.8%
自由现金流更多
RBCAA
多$154.6M
$6.5M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.5M | $94.3M |
| 净利润 | $5.7M | $22.8M |
| 毛利率 | 69.9% | — |
| 营业利润率 | 11.5% | 29.3% |
| 净利率 | 6.8% | 24.2% |
| 营收同比 | 117.4% | 5.3% |
| 净利润同比 | 138.3% | 20.0% |
| 每股收益（稀释后） | $0.10 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLLNRBCAA
| Q4 25 | — | $94.3M | ||
| Q3 25 | $83.5M | $93.5M | ||
| Q2 25 | — | $93.8M | ||
| Q1 25 | — | $135.8M | ||
| Q4 24 | — | $89.5M | ||
| Q3 24 | $38.4M | $88.1M | ||
| Q2 24 | — | $86.9M | ||
| Q1 24 | — | $120.3M |
净利润BLLNRBCAA
| Q4 25 | — | $22.8M | ||
| Q3 25 | $5.7M | $29.7M | ||
| Q2 25 | — | $31.5M | ||
| Q1 25 | — | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $-14.9M | $26.5M | ||
| Q2 24 | — | $25.2M | ||
| Q1 24 | — | $30.6M |
毛利率BLLNRBCAA
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率BLLNRBCAA
| Q4 25 | — | 29.3% | ||
| Q3 25 | 11.5% | 40.4% | ||
| Q2 25 | — | 43.0% | ||
| Q1 25 | — | 44.1% | ||
| Q4 24 | — | 25.8% | ||
| Q3 24 | -32.9% | 38.4% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 32.2% |
净利率BLLNRBCAA
| Q4 25 | — | 24.2% | ||
| Q3 25 | 6.8% | 31.8% | ||
| Q2 25 | — | 33.5% | ||
| Q1 25 | — | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | -38.8% | 30.1% | ||
| Q2 24 | — | 29.0% | ||
| Q1 24 | — | 25.4% |
每股收益（稀释后）BLLNRBCAA
| Q4 25 | — | — | ||
| Q3 25 | $0.10 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.47 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.2M | $220.0M |
| 总债务越低越好 | $55.0M | — |
| 股东权益账面价值 | $-239.5M | $1.1B |
| 总资产 | $327.5M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BLLNRBCAA
| Q4 25 | — | $220.0M | ||
| Q3 25 | $195.2M | $484.2M | ||
| Q2 25 | — | $484.8M | ||
| Q1 25 | — | $793.0M | ||
| Q4 24 | — | $432.2M | ||
| Q3 24 | — | $530.9M | ||
| Q2 24 | — | $400.1M | ||
| Q1 24 | — | $546.4M |
总债务BLLNRBCAA
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BLLNRBCAA
| Q4 25 | — | $1.1B | ||
| Q3 25 | $-239.5M | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $992.0M | ||
| Q3 24 | $-242.9M | $979.7M | ||
| Q2 24 | — | $955.4M | ||
| Q1 24 | — | $935.6M |
总资产BLLNRBCAA
| Q4 25 | — | $7.0B | ||
| Q3 25 | $327.5M | $7.0B | ||
| Q2 25 | — | $7.0B | ||
| Q1 25 | — | $7.1B | ||
| Q4 24 | — | $6.8B | ||
| Q3 24 | — | $6.7B | ||
| Q2 24 | — | $6.6B | ||
| Q1 24 | — | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $6.5M | $161.1M |
| 自由现金流率自由现金流/营收 | 7.7% | 170.9% |
| 资本支出强度资本支出/营收 | 8.8% | 7.5% |
| 现金转化率经营现金流/净利润 | 2.42× | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流BLLNRBCAA
| Q4 25 | — | $168.2M | ||
| Q3 25 | $13.8M | $33.3M | ||
| Q2 25 | — | $8.4M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $149.0M | ||
| Q3 24 | — | $51.3M | ||
| Q2 24 | — | $4.0M | ||
| Q1 24 | — | $71.2M |
自由现金流BLLNRBCAA
| Q4 25 | — | $161.1M | ||
| Q3 25 | $6.5M | $30.8M | ||
| Q2 25 | — | $5.2M | ||
| Q1 25 | — | $91.6M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | — | $49.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率BLLNRBCAA
| Q4 25 | — | 170.9% | ||
| Q3 25 | 7.7% | 32.9% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 67.4% | ||
| Q4 24 | — | 160.0% | ||
| Q3 24 | — | 56.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度BLLNRBCAA
| Q4 25 | — | 7.5% | ||
| Q3 25 | 8.8% | 2.6% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.7% |
现金转化率BLLNRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | 2.42× | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
RBCAA
暂无分部数据
